Brokerages Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $60.64
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have been given an average rating of “Buy” by the twelve research firms that are presently covering the firm, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The […]
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have been given an average rating of “Buy” by the twelve research firms that are presently covering the firm, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The […]
